I'm green and it only took 15 years and 23 average down events.
Let's not consider opportunity cost for a while! The amount of capital gains tax AGEN helped me avoid over thos 15 years is also considerable. Key, if i don't get to keep the money, why should Uncle Sam?
If they ran the company based on homophobic beliefs like yours, your shares would soon have the same value as your ideas. And, I'm pretty sure you would not like that that very much! You invest in J&J because it returns divs and capital appreciation. Why not consider the possibility that they know what they're doing, even if you do not!
Use your head and ask yourself why Merck might want to continue such an arrangement. That's what rational investors are supposed to do. That's what your head is for!
If management were separated from the company, the sum of the parts would be worth more than the parts individually. All that's needed here is some simple subtraction to get the valuation corrected.
If Apple are not paying for the service to Siri users then Nuance should simply shut down the servers Apple to poling. Business is business and Apple has none of the attributes of a charity! There seems to be a serious management problem at Nuance.
"The ruling means Amarin can give doctors and others truthful accounts of medical studies of the drug for reducing moderately high blood fats even when the FDA hasn't approved it for such use."
How did we get to a point where the FDA can prevent a company sharing the results of drug trials with doctors?
This ruling shows just how screwed up the regulatory side of drug development has become.
Time for an overhaul, perhaps the FDA needs to be taken apart and rebuilt using more sane principles.
Clearly mgt is doing a good job, putting the company in a place where it's impervious to large market corrections!
Well, I must be a sucker for punishment, i added more shares today even though I expect it'll continue going south until management can concoct a credible story that would allow for the possibiliy of the company surviving.
The absolutely incredible value of long read technology and PACB's almost complete failure to commercialize that opportunity makes me wonder if a larger player might not step in and rescue the situation before current management destroy what's left.
Are you suggesting management did not put us in this 'enviable' position?
You do realize the most you can now lose per share is 36 cents?
Do you own another security where your maximum losses per share are limited to 36 cents?.
Clearly management should be rewarded for their creativity in limiting future per share losses for shareholders! Those guys never stop thinking about their shareholders!
What's more noteworthy about the decision is that It makes Amarin a potential buy-out candidate.
Amarin's likely inability to commercially exploit the new reality does not mean larger, more competent players will not see the possibilities. Since the pharma space is a dog-eat-dog world, I would not expect Amarin's continual commercial failures to go unnoticed.
What's the point watching headless chickens running in random directions, I mean Wall Street.
I think she could be sued for that article. Amarin is seeking to share the results of a successful phase 3 trial on a marketed product with doctors. The artcile does not mention what Amarin is suing for. The article is a distortion of the case, to the point where the facts the facts are turned on their head.
Well unfortunately that $850 million is simply borrowed money so it would be inaccurate to call it cash from operations. it belongs to the lenders that Yandex borrowed it from.
This brings us back to my original question. Of the considerable cashflow from the business can anyone explain where it all went. Why is none of it on the balance sheet? Is this a financial management issue or a business model issue. As a comparison, take a look at QIWI. there we see strong financial management and accumulated cash from operations on the balance sheet.